Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2022 Earnings

2NovConfirmed

Q1 2022

Q2 2022

Q3 2022

Q4 2022

-0.67

-0.5

-0.34

-0.17

Details

Expected EPS

-0.2

Actual EPS

-0.17

Surprise EPS

0.03

Surprise Percent

+15%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.17 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.